Much has been said about the risks facing the infant formula producers recently, but it appears that investors may be forgetting the enormous opportunity that has also been put in front of them.

After they soared to new heights at the end of 2015, shares of companies such as Bellamy’s Australia Ltd (ASX: BAL) and a2 Milk Company Ltd (Australia) (ASX: A2M) have come crashing back down so far this year.

Blackmores Limited (ASX: BKL), a vitamins provider which only recently expanded into producing infant formula as well, has also been hit hard. Its shares are currently fetching around $171, down from almost $221 in December.

The reason behind these falls can largely be attributed to the various regulatory changes made by China in recent months. While these risks are certainly worth considering before buying into the shares the pullback in share prices could also be a great opportunity to reassess the merits of the industry.

All three of the companies mentioned above have enjoyed remarkable growth over the last 12 months or so, spurred by booming demand in China. Australian sales have also skyrocketed, although it is believed that many of these products are also purchased with the intention of selling to China through so-called ‘grey markets’.

By increasing their direct sales to China, these companies can take advantage of superior margins on their products, which should result in even greater profitability down the track.

There is also the baby boom in China to consider. China lifted its highly controversial and decades-long one-child policy last year, which is already showing signs of higher birth rates, according to a report in The Australian Financial Review.

Earlier this year, The Daily Mail UK also noted the cultural appeal of having babies born in the Year of the Monkey (2016), based on the fact that the monkey is deemed to be one of the luckier zodiac animals.

It said: “In some extreme cases, expectant mothers whose due dates fell at the end of the Year of the Sheep have resorted to extreme methods in a bid to delay their child’s birth.”

The Daily Mail UK also noted that doctors in China are advising expectant mothers to book ‘well in advance’ so as to not risk missing out, while three to six-million babies are also expected to be born in the next 12 months.

Understandably, Chinese nationals want their local infant formula producers to benefit from this trend as well. As such, they have made it more difficult for western-based companies to sell their goods in the country.

Assuming that Bellamy’s, Blackmores and a2 Milk can all get the necessary approvals to continue selling their products it would clearly be a good thing for these businesses, particularly at a time where more babies are entering the world and will need baby formula.

Despite their recent falls, shares across the industry are not necessarily ‘cheap’, but they could offer good value for investors with a long-term outlook.

When renowned dividend investing pros like Andrew Page issue buy alerts, it pays to listen. Because investors who followed Andrew's recommendation of Australian Pharmaceuticals in early 2015 could've doubled their money in just over a year, turning $15,000 into over $30,000 by the time he recommended they sell and lock in their profits. Chances are you won't want to miss uncovering the names of Andrew's newest share recommendation and short list of 3 dividend Best Buys Now Shares.
So click here to learn more about these potentially life-changing shares.

HOT OFF THE PRESSES: Motley Fool’s #1 Dividend Pick for 2017!

With its shares up 155% in just the last five years, this ‘under the radar’ consumer favourite is both a hot growth stock AND our expert’s #1 dividend pick for 2017. Now we’re pulling back the curtain for you... And all you have to do to discover the name, code and a full analysis is enter your email below!

Simply enter your email now to receive your copy of our brand-new FREE report, “The Motley Fool’s Top Dividend Stock for 2017.”

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our https://www.fool.com.au/financial-services-guide">Financial Services Guide (FSG) for more information.

Motley Fool contributor Ryan Newman owns shares of Bellamy's Australia. The Motley Fool Australia owns shares of Bellamy's Australia. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.